Regent strengthens leadership team with new VP of business development

Regent Surgical Health named Justin Neerhof vice president of business development.

Advertisement

 

Mr. Neerhof previously served as director of business development for Sovereign Healthcare, responsible for new service line growth and leading physician recruitment for the company’s multispecialty surgery centers. He also has prior experience as a sales territory leader for Stryker Orthopaedics.

“Justin’s track record of creating mutually beneficial joint venture partnership agreements and his experience recruiting surgeon partners are true assets as we drive toward our growth objectives in 2020,” said Regent’s Chief Development Officer Thomas Crossen.

Regent focuses on ASC joint venture partnerships with hospitals and health systems across the U.S. The company has 28 ASC partners, including 21 joint ventures, and 14 of those centers include total joint replacements. Three centers are involved in bundled payments.

In his new role, Mr. Neerhof will work with physician groups and health systems to merge, acquire and develop ASCs.

More articles on surgery centers:
4 experts weigh in on 2020 trends
Surgical Care Affiliates names new CEO
5 ASC revenue cycle tips

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Leadership

Advertisement

Comments are closed.